Publications by:
Gerald Münch
Also publishes as (Gerald Munch, Gerald Muench, G. Mϋnch, G. Münch, G. Muench)
Up a level |
Lamb, Lydia S., Alfonso, Helman, Norman, Paul E., Davis, Timothy M.E., Forbes, Josephine, Muench, Gerald, Irrgang, Felix, Almeida, Osvaldo P., Golledge, Jonathan, Hankey, Graeme J., Flicker, Leon, and Yeap, Bu B. (2018) Advanced glycation end products and esRAGE are associated with bone turnover and incidence of hip fracture in older men. Journal of Clinical Endocrinology and Metabolism, 103 (11). pp. 4224-4231.
Steele, Megan L., Fuller, Stacey, Maczurek, Annette E., Kersaitis, Cindy, Ooi, Lezanne, and Münch, Gerald (2013) Chronic inflammation alters production and release of glutathione and related thiols in Human U373 astroglial cells. Cellular and Molecular Neurobiology, 33 (1). pp. 19-30.
Zhang, Lin, Ravipati, Anjaneya S., Koyyalamudi, Sundar Rao, Jeong, Sang Chul, Reddy, Narsimha, Smith, Paul T., Bartlett, John, Shanmugam, Kirubakaran, Münch, Gerald, and Wu, Ming Jie (2011) Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds. Journal of Agricultural and Food Chemistry, 59 (23). pp. 12361-12367.
Krautwald, Martina, Maxwell, Philippa, Stuchbury, Grant, Holtum, Joe, Burnell, James, and Munch, Gerald (2009) The thiamine analogue and advanced glycation endproducts crosslink breaker ALT-711 does not interfere with transketolase activity. Open Longevity Science, 3. pp. 11-15.
Bigl, Katrin, Gaunitz, Frank, Schmitt, Annett, Rothemund, Sven, Schliebs, Reinhard, Münch, Gerald, and Arendt, Thomas (2008) Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. Journal of Neural Transmission, 115 (11). pp. 1545-1556.
Maczurek, Annette, Hager, Klaus, Kenklies, Marlene, Sharman, Matt, Martins, Ralph, Engel, Jürgen, Carlson, David A., and Münch, Gerald (2008) Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Advanced Drug Delivery Reviews, 60 (13). pp. 1463-1470.
Berbaum, Katrin, Shanmugam, Kirubakaran, Stuchbury, Grant, Wiede, Florian, Körner, Heinrich, and Münch, Gerald (2008) Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine, 41 (3). pp. 198-203.
Maczurek, Annette, Shanmugam, Kirubakaran, and Münch, Gerald (2008) Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Annals of the New York Academy of Sciences, 1126. pp. 147-151.
Shanmugam, Kirubakaran, Holmquist, Lina, Steele, Megan, Stuchbury, Grant, Berbaum, Katrin, Schulz, Oliver, Garcia, Obdulio Benavente, Castillo, Julian, Burnell, Jim, Garcia Rivas, Vernon, Dobson, Geoff, and Muench, Gerald (2008) Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages. Molecular Nutrition & Food Research, 52 (4). pp. 427-438.
Schmidt, A., Kuhla, B., Bigl, K., Münch, G., and Arendt, T. (2007) Cell cycle related signalling in neuro2A cells proceeds via the receptor for advanced glycation end products. Journal of Neural Transmission, 114 (11). pp. 1413-1424.
Bigl, Katrin, Schmitt, Annett, Meiners, Ina, Muench, Gerald, and Arendt, Thomas (2007) Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts. Toxicology in Vitro, 21 (5). pp. 962-971.
Garcia de Arriba, Susana, Stuchbury, Grant, Yarin, Jennifer, Burnell, Jim, Loske, Claudia, and Münch, Gerald (2007) Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells—protection by carbonyl scavengers. Neurobiology of Aging, 28 (7). pp. 1044-1050.
Kuhla, B, Haase, Cathleen, Flach, Katharina, Luth, Hans-Joachim, Arendt, Thomas, and Muench, Gerald (2007) Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on Tau aggregation and filament formation. Journal of Biological Chemistry, 282 (10). pp. 6984-6991.
Kuhla, B, Boeck, Katharina, Schmidt, Angela, Ogunlade, Vera, Arendt, Thomas, Münch, Gerald, and Lüth, Hans-Joachim (2007) Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiology of Aging, 28 (1). pp. 29-41.
Holmquist, Lina, Stuchbury, Grant, Berbaum, Katrin, Muscat, Sonja, Young, Simon, Hager, Klaus, Engel, Jürgen, and Münch, Gerald (2007) Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacology and Therapeutics, 113 (1). pp. 154-164.
Muscat, Sonja, Pelka, Joana, Hegele, Jorg, Weigle, Bernd, Muench, Gerald, and Pischetsrieder, Monika (2007) Coffee and Maillard products activate NF-jB in macrophages via H2O2 production. Molecular Nutrition & Food Research, 51 (5). pp. 525-535.
Holmquist, L., Stuchbury, G., Steele, M., and Münch, G. (2007) Hydrogen peroxide is a true first messenger. Journal of Neural Transmission, Supplementa, 72. pp. 39-41.
Hager, K., Kenklies, M., McAfoose, J., Engel, J., and Münch, G. (2007) α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis. Journal of Neural Transmission, Supplementa, 72. pp. 189-193.
Kirubakaran, Shanmugam, Maczurek, Annette, Young, Simon, and Münch, Gerald (2007) α-lipoic acid in the treatment of diabetic polyneuropathy and Alzheimer’s disease. International Journal of Biomedical and Pharmaceutical Sciences, 1 (2). pp. 105-111.
Steele, Megan, Stuchbury, Grant, and Münch, Gerald (2007) The molecular basis of the prevention of Alzheimer’s disease through healthy nutrition. Experimental Gerontology, 42 (1). pp. 28-36.
Kuhla, Björn , Boeck, Katharina, Lüth, Hans-Joachim, Schmidt, Angela, Weigle, Bernd, Schmitz, Marc, Ogunlade, Vera, Münch, Gerald, and Arendt, Thomas (2006) Age-dependent changes of glyoxalase I expression in human brain. Neurobiology of Aging, 27 (6). pp. 815-822.
Langer, André K., Poon, H. Fai, Münch, Gerald, Lynn, Bert C., Arendt, Thomas, and Butterfield, D. Allan (2006) Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells. Neurotoxicity Research, 9 (4). pp. 255-268.
de Arriba, Susana Garcia , Krügel, Ute, Regenthal, Ralf, Vissiennon, Zacharie, Verdaguer, Esther, Lewerenz, Anne, Garcia-Jorda, Elvira, Pallas, Merce, Camins, Antoni, Münch, Gerald, Nieber, Karen, and Allgaier, Clemens (2006) Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity. Free Radical Biology and Medicine, 40 (5). pp. 779-790.
Huber, Anke, Stuchbury, Grant, Bürkle, Alex, Burnell, Jim, and Münch, Gerald (2006) Neuroprotective therapies for Alzheimer's disease. Current Pharmaceutical Design, 12 (6). pp. 705-717.
Kuhla, Björn, Lüth, Hans-Joachim, Haferburg, Dietrich, Weick, Michael, Reichenbach, Andreas, Arendt, Thomas, and Münch, Gerald (2006) Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. Journal of Neuroscience Research, 83 (8). pp. 1591-1600.
Schmitt, Annett, Meiners, Ina, Schmitt, Johannes, Noller, Joachim, Ihling, Christian, Muench, Gerald, Sinz, Andrea, and Nieber, Karen (2005) Two analytical methods to study the interaction of AGEs with cell surface proteins. Journal of Biochemical and Biophysical Methods, 65 (2-3). pp. 121-136.
Kuhla, Björn, Lüth, Hans-Joachim, Haferburg, Dietrich, Boeck, Katharina, Arendt, Thomas, and Münch, Gerald (2005) Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Annals of the New York Academy of Sciences, 1043. pp. 211-216.
Ahmed, N., Ahmed, U., Hager, K., Fleischer, G., Münch, G., and Thornalley, P.J. (2005) Protein glycation marker residues and free adducts of cerebrospinal fluid in Alzheimer’s disease and a link to cognitive impairment. Annals of the New York Academy of Sciences, 1043. p. 914.
Münch, Gerald, Berbaum, Katrin, Urban, Christin, and Schinzel, Reinhard (2005) Proteins of Thermus thermophilus are resistant to glycation-induced protein precipitation: an evolutionary adaptation to life at extreme temperatures? Annals of the New York Academy of Sciences, 1043. pp. 865-875.
Richter, Torsten, Muench, Gerald, Luth, Hans-Joachim, Arendt, Thomas, Kientsch-Engel, Rosemarie, Stahl, Peter, Fengler, Dörte, and Kuhla, Björn (2005) Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts". Neurobiology of Aging, 26 (4). pp. 465-474.
Schmitt, Annett, Schmitt, Johannes, Münch, Gerald, and Gasic-Milencovic, Jovana (2005) Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Analytical Biochemistry, 338 (2). pp. 201-215.
Stuchbury, G., and Münch, G. (2005) Alzheimer's associated inflammation, potential drug targets and future therapies. Journal of Neural Transmission, 112 (3). pp. 429-453.
Luth, Hans-Joachim, Ogunlade, Vera, Kuhla, Björn, Kientsch-Engel, Rosemarie, Stahl, Peter, Webster, Julie, Arendt, Thomas, and Muench, Gerald (2005) Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cerebral Cortex, 15 (2). pp. 211-220.
Ahmed, Naila, Ahmed, Usman, Thornalley, Paul J., Hager, Klaus, Fleischer, Gerd, and Muench, Gerald (2005) Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. Journal of Neurochemistry, 92 (2). pp. 255-263.
Webster, Julie, Urban, Christin, Berbaum, Katrin, Loske, Claudia, Alpar, Alan, Gärtner, Ulrich, de Arriba, Susana Garcia, Arendt, Thomas, and Münch, Gerald (2005) The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotoxicity Research, 71 (1-2). pp. 95-101.
Mϋnch, G. (2005) Glycation and physiological mechanisms of its prevention in Alzheimer's disease. In: Sames, Klaus, Sethe, Sebastian, and Stolzing, Alexandra, (eds.) Extending the Lifespan: biotechnical, gerontological and social problems. LIT Verlag, Mϋnster, Germany, pp. 103-106.
Webster, J., Wilke, M., Stahl, P., Kientsch-Engel, R., and Münch, G. (2005) Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases. Zeitschrift fuer Gerontologie und Geriatrie, 38 (5). pp. 347-353.
Wihler, C., Schafer, S., Schmid, K., Deemer, E.K., Muench, G., Bleich, M., Busch, A.E., Dingermann, T., Somosa, V., Baynes, J.W., and Huber, J. (2005) Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition. Diabetologia, 48 (8). pp. 1645-1653.
Chen, Feng, Wollmer, M. Axel, Hoerndli, Frederic, Münch, Gerald, Kuhla, Björn, Rogaev, Evgeny I., Tsolaki, Magdalini, Papassotiropoulos, Andreas, and Götz, Jürgen (2004) Role for glyoxalase I in Alzheimer's disease. National Academy of Sciences. Proceedings, 101 (20). pp. 7687-7692.
Robinson, Stephen R., Bishop, Glenda M., Lee, Hyoung-gon, and Münch, Gerald (2004) Lessons from the AN 1792 Alzheimers vaccine: lest we forget. Neurobiology of Aging, 25 (5). pp. 609-615.